Patents by Inventor Christopher M. Turner

Christopher M. Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080075570
    Abstract: A pallet on which a product is shipped is provided with a lifting capability built into the pallet. By inclusion of the lifting capability in accordance with this invention, moving a product from horizontal to vertical position is facilitated.
    Type: Application
    Filed: September 25, 2006
    Publication date: March 27, 2008
    Inventors: Paul J. Cance, William J. Green, Christopher M Turner
  • Patent number: 7311203
    Abstract: A packaging apparatus comprising a pulp-based composition that provides protection to an equipment component (or other fragile or breakable item), provides ease in use during pre-packing and packing of an equipment component for transport, does not require the need for additional packing components in combination with the packaging assembly, provides shock protection during transport, is reusable, and is economically suited for its end use, is provided for. In accordance with one aspect of the present invention, the present invention is a molded, one piece packing assembly comprised of substantially a pulp-based composition. The present invention is advantageously designed using specific geometries which, contrary to traditional designs, benefit from the stressing and flexing characteristics of paper fiber.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: December 25, 2007
    Assignee: Lenovo (Singapore) Pte. Ltd.
    Inventors: Mark E. Maresh, Eric A. Stegner, Christopher M. Turner
  • Patent number: 6846668
    Abstract: The microfabricated cell injector having an injection wall and a cell injection needle projecting from the wall for piercing cells suspended in a fluid. The needle is held within a housing defined by the internal surfaces of the microfabricated cell injector. The housing has an inlet for suspended cells to enter and an outlet for cells to exit via the cell injection needle. A cell propulsion device is provided for impelling cells towards the needle such that, in use, cells suspended in the fluid are impelled towards the injection wall by the injection needle.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: January 25, 2005
    Assignee: AstraZeneca AB
    Inventors: Andrew J. Garman, David J. Scanlon, John Dodgson, John Ea Shaw, David Brennan, Anthony R. Corless, Christopher M. Turner
  • Publication number: 20040253609
    Abstract: The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in prostate cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the treatment of a subject with prostate cancer.
    Type: Application
    Filed: January 6, 2004
    Publication date: December 16, 2004
    Applicant: Incyte Corporation
    Inventors: Mary Faris, Christopher M. Turner
  • Patent number: 6808929
    Abstract: The invention relates to a microfabricated device for use in measuring the physical properties of compounds, where the properties measured using such devices are those which involve partitioning of the compound between two phases, measuring partition coefficients, distribution coefficients, acid-base dissociation constants, solubility and vapour pressure. The device comprises a microfabricated conduit, in which two fluids flow creating at least two phases between which the compound may partition, and a detector for measuring the amount of compound in each or both fluids.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: October 26, 2004
    Assignee: AstraZeneca AB
    Inventors: Brian Law, Bryan J A Miller, Christopher M Turner, John E A Shaw
  • Patent number: 6673545
    Abstract: The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in prostate cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the treatment of a subject with prostate cancer.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: January 6, 2004
    Assignee: Incyte Corporation
    Inventors: Mary Faris, Christopher M. Turner
  • Publication number: 20030175704
    Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in respiratory disorders and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a respiratory disorder including lung cancer, chronic obstructive pulmonary disease, emphysema, and asthma.
    Type: Application
    Filed: October 4, 2001
    Publication date: September 18, 2003
    Inventors: Amy K. W. Lasek, Andrew W. Shyjan, Christopher M. Turner
  • Publication number: 20020119463
    Abstract: The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in prostate cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the treatment of a subject with prostate cancer.
    Type: Application
    Filed: July 30, 2001
    Publication date: August 29, 2002
    Inventors: Mary Faris, Christopher M. Turner